Focus on Anticoagulation Care

Back to articles

Genetic analysis may help predict bleeding risk with warfarin

KEY POINT

Genotyping for variants in CYP2C9 and VKORC1 can help predict which patients on warfarin therapy are at an increased risk of bleeding and when alternative oral anticoagulants (i.e., edoxaban [Savaysa—Daiichi Sankyo]) may be a safer option.